Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Frank, R. D.
Right arrow Articles by Kierdorf, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frank, R. D.
Right arrow Articles by Kierdorf, H. P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2002) 17: 1957-1963
© 2002 European Renal Association-European Dialysis and Transplant Association

In vitro studies on hirudin elimination by haemofiltration: comparison of three high-flux membranes

Rolf Dario Frank1,, Heiko Farber1, Regina Lanzmich1, Jürgen Floege1 and Horst Peter Kierdorf2

1 Department of Nephrology and Clinical Immunology, University Hospital Aachen and 2 Department of Nephrology, Klinikum Braunschweig, Braunschweig, Germany

Background. Recombinant hirudin (r-hirudin) is a highly selective thrombin inhibitor used for anticoagulation in heparin-induced thrombocytopenia type II. R-hirudin is increasingly applied to patients with renal failure and on renal replacement therapy. Since kidney function impairment strongly prolongs r-hirudin elimination half-life, severe accumulation and bleeding complications may occur. Data on the r-hirudin permeability and elimination capacity of different haemofilters are limited.

Methods. Three haemofilter types were investigated: high-flux polysulphone (Fresenius), AN69 (Hospal), and polyamide (Gambro). We used two in vitro haemofiltration models: (i) an open post-dilution haemofiltration model with ultrafiltration and fluid substitution (model 1) simulating hirudin intoxication, and (ii) a closed model with ultrafiltrate reinfusion (model 2) to determine steady-state sieving coefficients (SC). Fresh human heparinized blood (2 IU unfractionated heparin/ml blood) was used. In model 2, SC obtained with human whole blood were compared with isotonic saline.

Results. In model 1, r-hirudin levels decreased significantly faster with polysulphone than with AN69 or polyamide (P<0.05). In accordance with this, in model 2 the observed SC in whole blood were 1.11±0.28 (polysulphone), 0.61±0.15 (AN69) and 0.33±0.13 (polyamide), and clearances were 28±7 (polysulphone), 15±4 (AN69) and 8±3 ml/min (polyamide) (P<0.001 for all comparisons). The SC in saline were slightly but significantly lower for polysulphone (0.88±0.12), similar for AN69 (0.59±0.1), and significantly improved for polyamide (0.83±0.1).

Conclusions. Elimination of r-hirudin by haemofiltration strongly depended on the membrane material. Using human blood, we observed large differences between the three high-flux membranes. The saline experiments suggest a membrane-dependent impact of plasma proteins and pH on hirudin sieving. Our findings have implications for r-hirudin dosage in haemofiltration, for treatment of overdosage, and for future in vitro haemofiltration studies.

Keywords: elimination; haemofiltration; hirudin; in vitro study; overdosage; sieving coefficient

Correspondence and offprint requests to: R. D. Frank, MD, Department of Nephrology, University Hospital Aachen, 52057 Aachen, Germany. Email: dario.frank{at}ukaachen.de


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
NDT PlusHome page
J. Bouchard and F. Madore
Role of citrate and other methods of anticoagulation in patients with severe liver failure requiring continuous renal replacement therapy
NDT Plus, February 1, 2009; 2(1): 11 - 19.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
K. Benz, M. A. Nauck, J. Bohler, and K.-G. Fischer
Hemofiltration of Recombinant Hirudin by Different Hemodialyzer Membranes: Implications for Clinical Use
Clin. J. Am. Soc. Nephrol., May 1, 2007; 2(3): 470 - 476.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.